Faeth Therapeutics grants options for 68,000 shares to three new employees
FTH•Faeth Therapeutics granted three new employees options to purchase 68,000 shares under its 2026 Inducement Plan, effective November 4, 2026.
1. Option grants
The options vest 25% on each employee’s first start-date anniversary, with the remainder vesting in 36 substantially equal monthly installments. The awards have a 10-year term from the grant date, and vesting is subject to continued service.
